Device / Technology News

RSS

New AI score enhances monitoring of myelodysplastic neoplasms

Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms.

20 Jul 2026

Machine learning tool improves accuracy of genome mapping studies

University of Virginia School of Medicine scientists have identified a widespread source of error in a popular method for studying the genome – our genetic instructions – and created a machine-learning tool to correct it.

20 Jul 2026

New tumor organoids strengthen precision oncology research

Significant advances have been made in the development of patient-derived tumor "organoids" for preclinical research, in two new studies led by Weill Cornell Medicine investigators.

20 Jul 2026

Dissolving microneedles could improve photodynamic skin cancer treatment

Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells.

20 Jul 2026

AI-guided technique improves targeted therapy delivery for brain tumors

Researchers presented a groundbreaking artificial intelligence (AI)-guided technique today at the Society of NeuroInterventional Surgery's (SNIS) 23rd Annual Meeting that may improve the accuracy of delivering experimental therapies directly to malignant brain tumors.

20 Jul 2026

New tool detects hidden biases in medical training data

Researchers have built a tool to uncover hidden issues in the massive datasets used to train medical AI.

20 Jul 2026

AI may predict harmful chemical exposures affecting human health

Artificial intelligence is rapidly improving scientists' ability to detect chemicals in the environment and human body.

19 Jul 2026

New portable strip test accurately detects mosquito-borne viruses

A research team has developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that enables highly sensitive, portable detection of mosquito-borne viruses, using Chikungunya virus (CHIKV) as a model target.

17 Jul 2026

NIH grant supports AI development for glaucoma prognosis and care

The National Eye Institute (NEI) and National Institutes of Health (NIH) awarded Mingquan Lin, PhD, an assistant professor in the Division of Computational Health Sciences at the University of Minnesota Medical School, a 5-year, $3.7 million grant for his research on Developing Robust Multimodal AI for Primary Open-Angle Glaucoma Prognosis.

17 Jul 2026

New battery-powered device detects Bundibugyo Ebola virus in thirty minutes

Professor Yasutoshi Kido of the Graduate School of Medicine, Osaka Metropolitan University (OMU), in collaboration with K.K. DNAFORM and the National Institute for Biomedical Research (INRB) of the Democratic Republic of the Congo, is developing a portable rapid diagnostic system for Ebola virus disease (EVD) caused by Bundibugyo virus (BDBV).

17 Jul 2026

New laser technology detects counterfeit alcohol through sealed bottles

A laser-based technology being developed at Adelaide University could soon help authorities detect deadly counterfeit alcohol, expose wine fraud and even identify dangerous chemicals inside sealed bottles – all without opening them.

17 Jul 2026

Trans-tympanic optical stimulation of the cochlea evokes reliable auditory responses

A new study, using Mongolian gerbils as an animal model, demonstrated for the first time that trans-tympanic infrared laser stimulation of the cochlea evokes reliable, auditory-guided behaviour in awake animals without the need for genetic modification or invasive surgical implantation.

17 Jul 2026

G&H highlights end-to-end diagnostic device development at ADLM 2026

At the ADLM Clinical Lab Expo 2026, G&H will showcase how diagnostic and medical device companies can accelerate the development and commercialization of innovative healthcare technologies through a single partner offering multidisciplinary engineering, precision optics, photonics and ISO 13485-certified manufacturing.

17 Jul 2026

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company's SYNTAX platform across India.

From DNA Script 17 Jul 2026

BYK Strengthens its portfolio of measurement and testing instruments through a strategic acquisition in the autonomous driving market

BYK-Gardner USA, a subsidiary of the specialty chemicals group ALTANA, is acquiring perisens GmbH.

From Paul N. Gardner Company 17 Jul 2026

New model improves short- and long-term disease risk prediction

Researchers developed ALADYNOULLI, a Bayesian generative model that combines longitudinal health records, age, and polygenic risk to identify reproducible disease signatures across more than 683,000 participants. In UK Biobank testing, the framework achieved stronger short- and long-term risk discrimination than established clinical scores while revealing disease subgroups and genetic associations.

16 Jul 2026